comparemela.com
Home
Live Updates
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization : comparemela.com
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
/PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry...
Related Keywords
Thailand
,
Malaysia
,
South Korea
,
United States
,
Puerto Rico
,
Bangladesh
,
Seoul
,
Soult Ukpyolsi
,
Singapore
,
Vietnam
,
Republic Of
,
Brazil
,
Sang Gi
,
Cholla Bukto
,
America
,
Joobin Jung
,
,
Hyundai Bioscience
,
South America
,
Southeast Asia
,
Bioscience United States
,
Global Marketing Manager
,
Health Care Amp Hospitals
,
Infection Control
,
Medical Pharmaceuticals
,
Biotechnology
,
New Products Amp Services
,
International Medical Approval
,
comparemela.com © 2020. All Rights Reserved.